Allurion Technologies (ALUR) Change in Account Payables (2022 - 2026)
Allurion Technologies (ALUR) reported Change in Account Payables of -$347000.0 for Q1 2026, up 85.6% on a YoY basis from -$186965.6 in Q1 2025, and down 151.56% quarter-over-quarter from $673000.0 in Q4 2025.
Allurion Technologies (ALUR) Change in Account Payables (2022 - 2026) Analysis & Trends
Allurion Technologies has reported Change in Account Payables for 5 years, with the latest figure at -$347000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables rose 85.6% year-over-year to -$347000.0; the trailing twelve-month figure through Mar 2026 stood at -$1.1 million (up 86.31% YoY), and the FY2025 full-year result was -$3.1 million, up 19.95% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$347000.0, down from $673000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $5.4 million in Q1 2023, with the low at -$4.1 million in Q2 2024.
- Historically, Change in Account Payables has averaged -$103133.3 across 5 years, with a median of -$333000.0 in 2023.
- Annual changes were most pronounced in 2023 — Change in Account Payables jumped 335.69% — and 2024, when it sank 1117.72%.
- Allurion Technologies' Change in Account Payables stood at $269000.0 in 2022, then soared by 335.69% to $1.2 million in 2023, then tumbled by 385.49% to -$3.3 million in 2024, then soared by 120.11% to $673000.0 in 2025, then sank by 151.56% to -$347000.0 in 2026.
- The last three Change in Account Payables figures came in at -$347000.0 (Q1 2026), $673000.0 (Q4 2025), and -$921000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 56.90 Mn |
| 10 | Allurion Technologies | - | - | 1.23 Mn | -347,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -347,000.00 |
| Mar 31, 2026 | -347,000.00 |
| Dec 31, 2025 | 673,000.00 |
| Dec 31, 2025 | 673,000.00 |
| Sep 30, 2025 | -921,000.00 |
| Sep 30, 2025 | -921,000.00 |
| Jun 30, 2025 | -484,000.00 |
| Jun 30, 2025 | -484,000.00 |
| Mar 31, 2025 | -2.41 Mn |
| Mar 31, 2025 | -2.41 Mn |
| Dec 31, 2024 | -3.35 Mn |
| Dec 31, 2024 | -3.35 Mn |
| Sep 30, 2024 | 1.93 Mn |
| Sep 30, 2024 | 1.93 Mn |
| Jun 30, 2024 | -4.06 Mn |
| Jun 30, 2024 | -4.06 Mn |
| Mar 31, 2024 | 1.55 Mn |
| Mar 31, 2024 | 1.55 Mn |
| Dec 31, 2023 | 1.17 Mn |
| Dec 31, 2023 | 1.17 Mn |